1. Frank, R., & Richard, H. (2003). Clinical biomarkers in drug discovery and development. Nature Reviews, 2, 566–580.
2. Yu, L.-R. (2011). Pharmacoproteomics and toxicoproteomics: the field of dreams. Journal of Proteomics, 74, 2549–2553.
3. Piotrowska-Seget, Z., & Mrozik, A. (2003). Signature lipid biomarker (SLB) analysis in determining changes in community structure of soil microorganisms. Polish Journal of Environmental Studies, 12, 669–675.
4. Meikle, P., Barlow, C., & Weir, J. (2009). Lipidomics and lipid biomarker discovery. Australian Biochemistry, 40, 12–16.
5. Hu, C., van der Heijden, R., Wang, M., van der Greef, J., Hankemeier, T., & Xu, G. (2009). Analytical strategies in lipidomics and applications in disease biomarker discovery. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 877, 2836–2846.